Ajay Samkaria/LinkedIn
Jun 9, 2026, 17:53
Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
Ajay Samkaria, Product and Application Manager at DIAGAST, shared a post on LinkedIn:
“ABO subgroups are more than just laboratory curiosities—they are clinically significant and can directly impact transfusion safety.
Weak or variant antigen expressions may lead to blood grouping discrepancies, incompatible transfusions, and delayed clinical decisions if not properly identified.
Highlights:
- Classification of A, B and O subgroups.
- Bombay (Oh) and Para Bombay phenotypes.
- Rare phenotypes such as INA and INB.
- Clinical and immunohematological significance.
- Common methods for subgroup confirmation.
Accurate detection and confirmation of ABO subgroups remain essential for safe transfusion practice and quality immunohematology reporting.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026